NBY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
NovaBay Pharmaceuticals Inc's quarterly additional paid-in capital declined from Sep. 2015 ($85.80 Mil) to Dec. 2015 ($85.39 Mil) but then increased from Dec. 2015 ($85.39 Mil) to Mar. 2016 ($88.25 Mil).
NovaBay Pharmaceuticals Inc's annual additional paid-in capital increased from Dec. 2012 ($54.00 Mil) to Dec. 2013 ($64.44 Mil) and increased from Dec. 2013 ($64.44 Mil) to Dec. 2014 ($72.88 Mil).
Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.
Additional Paid-In Capital is calculated as
|Additional Paid-In Capital||=||(Issue Price||-||Par Value)||*||Shares Outstanding|
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
NovaBay Pharmaceuticals Inc Annual Data
NovaBay Pharmaceuticals Inc Quarterly Data